Source:http://linkedlifedata.com/resource/pubmed/id/20061986
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-3-12
|
pubmed:abstractText |
This study evaluated the expression profile of hepatocyte growth factor (HGF), c-Met, epidermal growth factor receptor (EGFR), insulin-like growth factor-1 receptor (IGF-1R), and vitreal and serum EGF, HGF, IGF-1 levels in patients with uveal melanoma and assessed their correlation with the clinicopathological parameters. Forty patients with uveal melanoma were included in the study. Clinicopathological parameters were evaluated with hematoxylin-eosin staining. HGF, c-Met, EGFR, and IGF-1R expressions were evaluated immunohistochemically. HGF, EGF, and IGF-1 levels were measured with enzyme-linked immunosorbent assay in vitreous and serum specimens taken at enucleation and 6 months after the enucleation. HGF, c-Met, IGF-1R, and EGFR expressions were detected in 57.5, 20, 20, and 12.5% of cases, respectively. IGF-1R expression was significantly correlated with the degree of pigmentation, necrosis, and lymphocyte infiltration (P=0.013, 0.04, and 0.017). EGFR expression was significantly correlated with the mitosis rate (P=0.02). Vitreal EGF and serum IGF-1 levels were significantly higher in patients with scleral invasion (15.72+/-29.13, 199.01+/-154.01 pg/ml, respectively) when compared with the patients without invasion (0.56+/-1.05, 33.01+/-36.52 pg/ml) (P=0.03 and 0.015). When the preoperative and postoperative serum growth factor levels were compared, the serum EGF level was found to be lower (125.93+/-62.84, 100.02+/-31.19 pg/ml, P=0.007) and the serum IGF-1 level (165.81+/-153.6, 301.35+/-131.24 pg/ml, P<0.001) was found to be higher in the postoperative 6-month specimens. Uveal melanomas express HGF, c-Met, EGFR, and IGF-1R. Vitreal growth factor levels and expression of EGFR and IGF-1R are correlated with some clinicopathological parameters. IGF-1 and EGF may have a role in the development and progression of uveal melanoma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/HGF protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatocyte Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-met,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, IGF Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1473-5636
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
126-32
|
pubmed:meshHeading |
pubmed-meshheading:20061986-Adult,
pubmed-meshheading:20061986-Aged,
pubmed-meshheading:20061986-Aged, 80 and over,
pubmed-meshheading:20061986-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20061986-Female,
pubmed-meshheading:20061986-Hepatocyte Growth Factor,
pubmed-meshheading:20061986-Humans,
pubmed-meshheading:20061986-Immunohistochemistry,
pubmed-meshheading:20061986-Male,
pubmed-meshheading:20061986-Melanoma,
pubmed-meshheading:20061986-Middle Aged,
pubmed-meshheading:20061986-Proto-Oncogene Proteins c-met,
pubmed-meshheading:20061986-Receptor, Epidermal Growth Factor,
pubmed-meshheading:20061986-Receptor, IGF Type 1,
pubmed-meshheading:20061986-Tumor Markers, Biological,
pubmed-meshheading:20061986-Uveal Neoplasms
|
pubmed:year |
2010
|
pubmed:articleTitle |
Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
|
pubmed:affiliation |
Ocular Oncology Service, Hacettepe University School of Medicine, Ankara, Turkey.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|